Home A Pediatric Endocrinologist's View Of MannKind's Afrezza
 

Keywords :   


A Pediatric Endocrinologist's View Of MannKind's Afrezza

2015-11-05 13:08:14| Biotech - Topix.net

There have been many investment analyst opinions expressed about the coming success or failure of MannKind Corporation's new inhaled insulin, Afrezza. Sanofi , MannKind's pharmaceutical marketing partner, has invested millions of dollars in up front licensing fees, milestone payments, and Afrezza related costs in marketing and promotion.

Tags: view pediatric afrezza

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.11 HEXAGON TR SET UP
28.1121dc hg
28.111EX D
28.11 Bucchus IMP24 FMH-RSM/M
28.11
28.11specialites TA carmina 46-36
28.11HUNTER×HUNTER
28.11
More »